These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 19243360)
1. Nasal CpG oligodeoxynucleotide administration induces a local inflammatory response in nonallergic individuals. Månsson A; Bachar O; Adner M; Cardell LO Allergy; 2009 Sep; 64(9):1292-300. PubMed ID: 19243360 [TBL] [Abstract][Full Text] [Related]
2. Effects of TNFalpha on the human nasal mucosa in vivo. Widegren H; Korsgren M; Andersson M; Greiff L Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages. Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930 [TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide administration to the allergic nose contributes to lower airway inflammation. Bachar O; Gustafsson J; Jansson L; Adner M; Cardell LO Clin Exp Allergy; 2007 Dec; 37(12):1773-80. PubMed ID: 17941911 [TBL] [Abstract][Full Text] [Related]
6. Expression of Toll-like receptor 9 in nose, peripheral blood and bone marrow during symptomatic allergic rhinitis. Fransson M; Benson M; Erjefält JS; Jansson L; Uddman R; Björnsson S; Cardell LO; Adner M Respir Res; 2007 Feb; 8(1):17. PubMed ID: 17328813 [TBL] [Abstract][Full Text] [Related]
7. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge. Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327 [TBL] [Abstract][Full Text] [Related]
8. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis. Pullerits T; Lindén A; Malmhäll C; Lötvall J Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252 [TBL] [Abstract][Full Text] [Related]
9. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity. Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651 [TBL] [Abstract][Full Text] [Related]
10. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis. Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165 [TBL] [Abstract][Full Text] [Related]
12. Relationships between allergic inflammation and nasal airflow in children with seasonal allergic rhinitis. Ciprandi G; Tosca MA; Marseglia GL; Klersy C Ann Allergy Asthma Immunol; 2005 Feb; 94(2):258-61. PubMed ID: 15765742 [TBL] [Abstract][Full Text] [Related]
13. Systemic up-regulation of TLR4 causes lipopolysaccharide-induced augmentation of nasal cytokine release in allergic rhinitis. Ekman AK; Virtala R; Fransson M; Adner M; Benson M; Jansson L; Cardell LO Int Arch Allergy Immunol; 2012; 159(1):6-14. PubMed ID: 22555057 [TBL] [Abstract][Full Text] [Related]
14. Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis. Fransson M; Adner M; Erjefält J; Jansson L; Uddman R; Cardell LO Respir Res; 2005 Sep; 6(1):100. PubMed ID: 16146574 [TBL] [Abstract][Full Text] [Related]
15. Modification of allergic inflammation in murine model of rhinitis by different bacterial ligands: involvement of mast cells and dendritic cells. Yamamoto K; Kawamura I; Ito J; Mitsuyama M Clin Exp Allergy; 2006 Jun; 36(6):760-9. PubMed ID: 16776677 [TBL] [Abstract][Full Text] [Related]
16. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis. Won TB; Quan SH; Kim DY; Rhee CS; Lee CH Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603 [TBL] [Abstract][Full Text] [Related]
17. [Myeloperoxidase (MPO) as a marker of neutrophil influx into nasal mucosa after recombinant IL-8 challenge]. Kupczyk M; Bocheńska-Marciniak M; Górski P; Kuna P Pneumonol Alergol Pol; 2002; 70(11-12):544-9. PubMed ID: 12884563 [TBL] [Abstract][Full Text] [Related]
18. Airway function and nasal inflammation in seasonal allergic rhinitis and asthma. Ciprandi G; Cirillo I; Vizzaccaro A; Milanese M; Tosca MA Clin Exp Allergy; 2004 Jun; 34(6):891-6. PubMed ID: 15196276 [TBL] [Abstract][Full Text] [Related]
19. Cytosine-phosphate-guanine motifs fail to promote T-helper type 1-polarized responses in human neonatal mononuclear cells. Prescott SL; Irwin S; Taylor A; Roper J; Dunstan J; Upham JW; Burgner D; Richmond P Clin Exp Allergy; 2005 Mar; 35(3):358-66. PubMed ID: 15784116 [TBL] [Abstract][Full Text] [Related]
20. Effects of pollen and nasal glucocorticoid on FOXP3+, GATA-3+ and T-bet+ cells in allergic rhinitis. Malmhäll C; Bossios A; Pullerits T; Lötvall J Allergy; 2007 Sep; 62(9):1007-13. PubMed ID: 17686103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]